Radcliffe Capital Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-573,689
Closed -$6.37M – 47
2024
Q1
$6.37M Sell
573,689
-73,867
-11% -$816K 1.21% 18
2023
Q4
$7.09M Buy
647,556
+69,476
+12% +$756K 0.95% 24
2023
Q3
$6.26M Sell
578,080
-49,670
-8% -$533K 0.78% 34
2023
Q2
$6.7M Sell
627,750
-10,752
-2% -$114K 0.57% 40
2023
Q1
$6.7M Buy
638,502
+182,090
+40% +$1.89M 0.42% 64
2022
Q4
$4.68M Buy
456,412
+156,412
+52% +$1.59M 0.15% 212
2022
Q3
$3.02M Buy
+300,000
New +$3.01M 0.07% 458

Other funds holding RENE

Radcliffe Capital Management's RENE Position: Q2 2024 in Review

Radcliffe Capital Management sold out of Cartesian Growth Corp II (RENE) in Q2 2024, closing a stake of 573,689 shares — an estimated $6.37M sold.

Radcliffe Capital Management first reported a position in RENE in Q3 2022 and held it in 7 quarters. The position peaked at $7.09M in Q4 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q2 2024.

  • Radcliffe Capital Management reported no remaining Cartesian Growth Corp II position as of Q2 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 573,689 Cartesian Growth Corp II shares in Q2 2024, an estimated $6.37M.
  • Radcliffe Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 7 quarters.
  • Radcliffe Capital Management's Cartesian Growth Corp II position peaked at $7.09M in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2024.

Based on Radcliffe Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.